A PET Study: Single-dose, Open-label Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712.

Trial Profile

A PET Study: Single-dose, Open-label Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 31 May 2011

At a glance

  • Drugs HT 0712 (Primary)
  • Indications Cognition disorders
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 31 May 2011 Additional lead trial centre and company added as trial sponsor (Dart NeuroScience) as reported by ClinicalTrials.gov.
    • 31 May 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 11 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top